We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is... Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is in a Phase 1 clinical trial in patients with tumors expressing NaPi2b, including ovarian cancer, NSCLC, and other cancers. In addition, multiple partners are using Mersana's platform to advance their ADC pipelines. Show more
CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
Enrollment in dose escalation and backfill cohorts continuing in Phase 1 clinical trial of XMT-1660; expect to initiate tumor-specific expansion cohorts in the second quarter of 2024 and announce...
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
CAMBRIDGE, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.46 | -13.8972809668 | 3.31 | 3.35 | 2.745 | 2317672 | 3.04675032 | CS |
4 | -1.59 | -35.8108108108 | 4.44 | 4.64 | 2.745 | 1726064 | 3.63667714 | CS |
12 | -0.47 | -14.156626506 | 3.32 | 6.2801 | 2.745 | 2298491 | 4.46309927 | CS |
26 | 1.72 | 152.212389381 | 1.13 | 6.2801 | 1.065 | 2101872 | 3.31097504 | CS |
52 | -1.21 | -29.802955665 | 4.06 | 9.62 | 0.8014 | 3553207 | 2.74413527 | CS |
156 | -13.32 | -82.3747680891 | 16.17 | 17.16 | 0.8014 | 1949049 | 4.20970085 | CS |
260 | -1.64 | -36.5256124722 | 4.49 | 29.09 | 0.8014 | 1483685 | 6.78949887 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions